AbbVie Corporation Canada
AbbVie Corporation Canada is a company that takes on the toughest health challenges. But they do more than treat diseases—they aim to make a remarkable impact on people’s lives. They are AbbVie, a highly focused research-driven biopharmaceutical company.
Alexion Pharma Canada
Alexion is focused on providing innovative treatments to patients with severe and life-threatening rare diseases for which there are few, if any, effective treatment options. In 2009, Alexion began operations in Canada to serve patients locally. We aim to work in partnership with all stakeholders including healthcare providers, patient advocacy organizations and government in order to best serve patients. By expanding the knowledge and awareness of rare diseases, we help the medical community improve the process for diagnosis and treatment. Our goal is to bring hope to patients and families by delivering life-changing therapies.
In Canada, Soliris® has received marketing authorization from Health Canada for all patients with PNH. Soliris® is also approved by Health Canada as safe and effective for use in children and adults with atypical HUS to inhibit complement-mediated thrombotic microangiopathy (TMA). To further advance the understanding of PNH and atypical HUS in the Canadian population, Alexion Canada sponsors disease registries that enroll treated and untreated patients who are diagnosed with these conditions. This is our commitment to ongoing research into the rare conditions that our therapies treat.
Learn more about Alexion’s research and development efforts.
Astellas Pharma Canada, Inc
Astellas Pharma Canada, Inc. is a Canadian affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical company conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people in Canada and around the world.
AstraZeneca is a global, innovation-driven biopharmaceutical business with a focus on the discovery, development and commercialization of primary and specialty care medicines that transform lives. Our primary focus is on four important areas of healthcare: Cardiovascular, Renal and Metabolic disease (CVRM); Oncology; Respiratory and Immunology; and Rare Diseases. AstraZeneca operates in more than 100 countries and its innovative medicines are used by millions of patients worldwide. In Canada, we employ roughly 1,090 employees across the country and our headquarters are located in Mississauga, Ontario. The company invested $112 million in Canadian research and development in 2020 and is designated a Global Clinical Trial Delivery site – leading the delivery of more than 100 global clinical trials in oncology and respiratory disease.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Approximately 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing. The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 600 people across Canada. Learn more at www.boehringer-ingelheim.ca.
Horizon Therapeutics Canada
Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.ca and follow us on Twitter, LinkedIn, Instagram and Facebook.
Innovative Medicines Canada
Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry. We help our members discover, develop, and deliver innovative medicines and vaccines. Our membership consists of 50 companies, from established organizations to fledgling startups, all of whom are revolutionizing healthcare through the discovery and development of new medicines and vaccines. Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and stakeholders to advance the field and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system. We aim to achieve these goals by forming effective alliances, supporting policies, improving Canada’s regulatory environment, widening access to innovative medicines and ensuring the effective protection of intellectual property. We believe in ensuring that Canadians have access to the innovative treatments they need and that our activities are a fundamental part of safeguarding our healthcare system for future generations. Our work allows our members to focus on what matters: delivering better healthcare solutions to Canadians.
Johnson & Johnson, Family of Companies in Canada
As part of the world’s largest and most broadly-based healthcare company (comprised of Consumer Health, Pharmaceuticals and Medical Devices), we are committed to using our reach and size for good every day.
Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. This site is intended for residents of the United States and its territories.
Pfizer Canada strives to profoundly impact the health of Canadians through the discovery, development and delivery of medicines and vaccines. Our diverse portfolio offers a broad range of benefits and solutions to meet the needs of Canadians.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe. Sanofi entities in Canada employ approximately 1,900 people. In 2017 we invested over $123 million in R&D in Canada, creating jobs, business and opportunity throughout the country. Sanofi, Empowering Life.
Shift Health brings a science mindset to strategy consulting for the health research and innovation ecosystem.
We blend scientific depth, sector leadership and global perspective, tackling our clients’ most challenging questions with curiosity, rigour and courage.
Delivering sharp insights and customized solutions, we’re helping to create the future of healthcare.
Silicon Valley Bank
More than 35 years ago, Silicon Valley Bank was born into the heart of the innovation economy. We’ve believed in and worked with some of the world’s greatest innovators and their investors, helping to move their bold ideas forward, fast.
Our unique financial solutions, insights and connections have been helping Canadian technology and life science businesses and their investors to succeed. We understand how unpredictable development timelines, regulations and reimbursement cycles can stand in the way of innovation and growth. We provide financial services to help you hit your milestones.
In 2019 we opened an office in Toronto dedicated to lending to Canadian businesses and their investors.
In Canada, healthcare is a point of pride. And at Takeda Canada, we work every day for better health and a brighter future.
Patients are our motivation. From our roots in Japan, we have grown globally over 235 years, continuously asking ourselves, “How can we do more for our patients?” We are unwaveringly committed to patients at every step – because we know the journey doesn’t end when treatment begins. From efforts to ensure access to treatment to supporting physicians, we are dedicated to advancing healthcare in Canada.
Our way of thinking motivates us to invest in talent, technology and unique partnerships with research and development hubs to bring the most innovative treatments to market. These innovations, including Canadian-made treatments, improve – and save – lives, inspiring us to keep working harder.
With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences. To realize this potential, adMare uses its scientific and commercial expertise, specialized R&D infrastructure, and investment capital to build investable companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term.
BioTalent Canada™ is the catalyst for significant and sustainable growth in Canada’s bio-economy. We’re the HR partner of employers, associations, academia, immigrant serving agencies and service providers in this rapidly evolving sector. Our success is deeply rooted in current, reliable labour market data that helps industry recruit, train and retain the best and brightest. Our dynamic programs remain aligned with government priorities and connect job-ready talent to industry.
Recently named one of the 50 Best Workplaces in Canada with 10-50 employees and awarded a Great Place to Work® Certification 2021, BioTalent Canada practices the same industry standards it recommends to its stakeholders. These distinctions were awarded to BioTalent Canada following a thorough and independent analysis conducted by Great Place to Work®.
Stryker is one of the world’s leading medical technology companies and, together with our customers, is driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Taiho Pharma Canada Inc.
Taiho Pharma Canada, Inc., a Canadian subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), is located in Oakville, Ontario and managed by Taiho Oncology based in Princeton, New Jersey. Taiho Pharma’s mission in Canada is to lead oncology innovation, drive research and transform the lives of Canadians living with cancer. Taiho Oncology has established world class clinical development and commercial organizations that work urgently to develop and market innovative cancer treatments. Taiho Oncology Inc. has an oral oncology pipeline consisting of both novel anti-metabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state of the art facilities are helping Taiho define the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy.
Exceptional service begins with exceptional relationships. The best reason to choose BDO isn’t our service offerings, though they are among the most extensive in our industry. It isn’t our resources, though they are among the broadest in the world. It isn’t that we possess experience working with virtually every business sector in Canada, or that we offer the highest standards of technical excellence, though we do. Ultimately, the best reason to choose BDO comes down to the relationships we build with our clients and communities. Because at the end of the day, ours is a business of people working with, for, and in the service of others. And when you think about it that way, client service becomes more than just client service; it becomes a firm-wide dedication to helping the people we serve succeed – whatever they need, wherever they are, however we can.
CRB is a leading provider of sustainable engineering, architecture, construction and consulting solutions to the global life sciences and advanced technology industries. Our more than 1,600 employees provide best-in-class solutions that drive success and positive change for our clients, our people and our communities. CRB is a privately held company with a rich 37-year history of serving clients throughout the world, consistently striving for the highest standard of technical knowledge, creativity, and execution.
Ernst & Young LLP
At EY, we are committed to building a better working world — with increased trust and confidence in business, sustainable growth, development of talent in all its forms, and greater collaboration. We want to build a better working world through our own actions and by engaging with like-minded organizations and individuals. This is our purpose — and why we exist as an organization. Running through our organization is a strong sense of obligation to serve a number of different stakeholders who count on us to deliver quality and excellence in everything we do. We want to use our global reach and scale to convene the conversation about the challenges facing economies and the capital markets. When business works better, the world works better. Learn more about our commitment to building a better working world.
Innomar Strategies, Inc.
Since 2001, we have provided an unparalleled balance between patient care and market access, and continue to deliver innovative solutions to specialty manufacturers to improve product access, increase supply chain efficiency, and ultimately enhance patient care.
Niagara, Canada is open for business and the Niagara Economic Development team offers concierge-style support to businesses that are considering investment in the region. Whether you are an established Niagara business looking to expand, or a business from outside the region researching Niagara as a potential location for future investment, the Niagara Economic Development team can connect you with information, contacts, and referrals to numerous programs, incentives and services to help your business prosper.
Learn more about the free and confidential services available for your business.
University of Toronto Arts & Science Co-op
Simplify your recruiting process by partnering with the University of Toronto Arts & Science Co-op program. We offer the unique option of 4, 8 or 12-month work terms, allowing you to choose the duration that best suits your organization’s projects and needs. Students are available year-round from 35 programs including our top-ranked Biochemistry, Chemistry, Molecular Biology and Biotechnology, Neuroscience and Computer Science programs.
Our recruiting process is simple: recruit according to your timelines and make offers to your chosen candidate – we’ll handle the rest. From posting to hiring, we can help you find a great fit in as few as 10 days.